Royal Bank Of Canada Guardant Health, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Guardant Health, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 134,270 shares of GH stock, worth $4.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134,270
Previous 159,601 15.87%
Holding current value
$4.93 Million
Previous $4.61 Million 33.22%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$22.3 - $36.29 $564,881 - $919,261
-25,331 Reduced 15.87%
134,270 $3.08 Million
Q2 2024

Aug 14, 2024
BUY
$16.07 - $31.84 $288,504 - $571,623
17,953 Added 12.67%
159,601 $4.61 Million
Q1 2024

Nov 05, 2024
SELL
$17.13 - $26.91 $307,534 - $483,115
-17,953 Reduced 11.25%
141,648 $2.92 Million
Q1 2024

May 15, 2024
SELL
$17.13 - $26.91 $1.89 Million - $2.97 Million
-110,483 Reduced 43.82%
141,648 $2.92 Million
Q4 2023

Feb 14, 2024
SELL
$21.58 - $29.5 $609,138 - $832,696
-28,227 Reduced 10.07%
252,131 $6.82 Million
Q3 2023

Nov 14, 2023
BUY
$25.8 - $39.97 $808,365 - $1.25 Million
31,332 Added 12.58%
280,358 $8.31 Million
Q2 2023

Aug 14, 2023
BUY
$20.94 - $38.01 $281,328 - $510,664
13,435 Added 5.7%
249,026 $8.92 Million
Q1 2023

May 15, 2023
SELL
$22.92 - $33.76 $24,043 - $35,414
-1,049 Reduced 0.44%
235,591 $5.52 Million
Q4 2022

Feb 14, 2023
SELL
$25.44 - $59.78 $337,385 - $792,802
-13,262 Reduced 5.31%
236,640 $6.44 Million
Q3 2022

Nov 14, 2022
BUY
$43.66 - $61.0 $582,424 - $813,740
13,340 Added 5.64%
249,902 $13.5 Million
Q2 2022

Aug 15, 2022
SELL
$28.82 - $77.35 $700,700 - $1.88 Million
-24,313 Reduced 9.32%
236,562 $9.54 Million
Q1 2022

May 16, 2022
SELL
$48.25 - $100.49 $1.14 Million - $2.38 Million
-23,672 Reduced 8.32%
260,875 $17.3 Million
Q4 2021

Feb 14, 2022
SELL
$88.71 - $120.43 $2.03 Million - $2.75 Million
-22,860 Reduced 7.44%
284,547 $28.5 Million
Q3 2021

Nov 15, 2021
SELL
$98.77 - $132.17 $1.82 Million - $2.44 Million
-18,426 Reduced 5.66%
307,407 $38.4 Million
Q2 2021

Aug 16, 2021
BUY
$109.77 - $165.68 $35.8 Million - $54 Million
325,833 New
325,833 $40.5 Million

Others Institutions Holding GH

# of Institutions
323
Shares Held
127M
Call Options Held
844K
Put Options Held
2.38M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.75B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email